ProQR Therapeutics (PRQR) Total Debt (QoQ) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 46.74% |
| Sep 30, 2023 | -19.16% |
| Jun 30, 2023 | -7.07% |
| Mar 31, 2023 | -39.36% |
| Dec 31, 2022 | 43.64% |
| Sep 30, 2022 | -88.07% |
| Jun 30, 2022 | -6.39% |
| Mar 31, 2022 | -14.62% |
| Dec 31, 2021 | 144.22% |
| Sep 30, 2021 | 1.05% |
| Jun 30, 2021 | 102,555.74% |
| Mar 31, 2021 | -99.90% |
| Dec 31, 2020 | 6.67% |
| Sep 30, 2020 | 258.84% |
| Jun 30, 2020 | -62.78% |
| Mar 31, 2020 | 0.34% |
| Dec 31, 2019 | 23.53% |
| Sep 30, 2019 | 0.48% |
| Jun 30, 2019 | 10,778,453.03% |
| Mar 31, 2019 | -100.00% |
| Dec 31, 2018 | 145,768,054.77% |
| Sep 30, 2018 | -100.00% |
| Jun 30, 2018 | 102,081.72% |
| Mar 31, 2018 | -99.92% |
| Dec 31, 2016 | 151,925.02% |
| Mar 31, 2015 | -7.32% |
| Dec 31, 2014 | -3.68% |